Ligand Pharmaceuticals Incorporated (LGND): Price and Financial Metrics

LGND POWR Grades

• LGND scores best on the Quality dimension, with a Quality rank ahead of 74.69% of US stocks.
• The strongest trend for LGND is in Growth, which has been heading up over the past 178 days.
• LGND's current lowest rank is in the Stability metric (where it is better than 18.9% of US stocks).

LGND Stock Summary

• With a year-over-year growth in debt of -74.06%, LIGAND PHARMACEUTICALS INC's debt growth rate surpasses just 2.9% of about US stocks.
• As for revenue growth, note that LGND's revenue has grown -29.19% over the past 12 months; that beats the revenue growth of just 6.95% of US companies in our set.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for LGND comes in at 20.9% -- higher than that of 91.44% of stocks in our set.
• Stocks that are quantitatively similar to LGND, based on their financial statements, market capitalization, and price volatility, are NN, MTTR, VUZI, ZM, and HLGN.
• LGND's SEC filings can be seen here. And to visit LIGAND PHARMACEUTICALS INC's official web site, go to www.ligand.com.

LGND Valuation Summary

• In comparison to the median Healthcare stock, LGND's price/earnings ratio is 263.27% lower, now standing at -36.9.
• Over the past 243 months, LGND's price/sales ratio has gone up 2.1.

Below are key valuation metrics over time for LGND.

LGND Growth Metrics

Its year over year cash and equivalents growth rate is now at -52.93%.
• Its 4 year net cashflow from operations growth rate is now at -177.82%.
• The 2 year net income to common stockholders growth rate now stands at 138.66%.

LGND's revenue has moved down $654,000 over the prior 49 months.

The table below shows LGND's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	241.673	112.02	-21.292
2022-06-30	240.42	111.556	-7.973
2022-03-31	267.676	120.055	23.647
2021-12-31	277.133	78.798	57.138
2021-09-30	274.65	51.693	68.315
2021-06-30	251.663	44.413	47.891

LGND's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LGND has a Quality Grade of C, ranking ahead of 59.87% of graded US stocks.
• LGND's asset turnover comes in at 0.195 -- ranking 202nd of 681 Pharmaceutical Products stocks.
• NBIX, IRWD, and MNKD are the stocks whose asset turnover ratios are most correlated with LGND.

The table below shows LGND's key quality metrics over time.